| [1] |
DU Xiaoyu, LI Yumeng, WU Huizhen, QIU Bo.
Pharmacological and clinical evaluation of Dorzagliatin in the treatment of type 2 diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1177-1183.
|
| [2] |
BAI Jia, YANG Hong, LI Lingling, ZHANG Yangyang, YANG Ying, LV Haihong.
Study on the effect of vitamin D on diabetic neuropathy through mitochondrial/autophagy pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 214-219.
|
| [3] |
CAI Jing, PAN Binjing, LIU Jingfang.
Research progress on the relationship between hypoglycemic drugs and sarcopenia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 101-108.
|
| [4] |
LI Lingling, ZHANG Yangyang, BAI Jia, YANG Hong, YANG Ying, LV Haihong.
Progress in research on the effects of different glucagon-like peptide-1 receptor agonists on bone metabolism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1315-1320.
|
| [5] |
WANG Wenjuan, QI Mingrui, TIAN Limin.
Research progress on Nrf2 in diabetic cardiomyopathy and intervention of traditional Chinese medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1163-1170.
|
| [6] |
WANG Xin, LIU Weiying, WU Chen, KAI Jinjun, LIANG Xuejie, CHANG Yingxuan.
Metformin regulates AMPK/SREBP-1 pathway and its clinical application
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1049-1054.
|
| [7] |
LU Senlin, LIU Xinyuan, WANG Jili, HUANG Xiaofei.
Research progress of virus-mediated gene therapy in type 2 diabetes mellitu
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 800-807.
|
| [8] |
WANG Zhen, QUAN Haiyan, HONG Chenliang, YUAN Lijialong, QIN Xuping.
Swimming improves renal function of diabetic mice by promoting autophagy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 632-638.
|
| [9] |
ZENG Xiaofan, XU Yiqi, LIU Shu, WU Qian, LI Zibao, HE Junjun, JIN Yuelong, ZHAO Yongli, HE Chunling, GAO Jialin.
Retrospectively analysis of the effect of low-dose aspirin on primary prevention of non-fatal myocardial infarction and cerebral infarction in patients with type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 665-671.
|
| [10] |
CHENG Kuan.
New progress in research and application of fenneridone
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 450-456.
|
| [11] |
SHAO Xi, YU Yanan, HUANG Yuhan, WANG Xiaotong, LING Hongwei, LV Dongmei, WANG Tao.
Predictive factors associated with weight response to exenatide in patients with type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 287-294.
|
| [12] |
LV Xiaohan, LIN Rong.
Association of Lin28 with tumor, cardiovascular disease and diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 205-211.
|
| [13] |
LIU Xiaoling, SONG Zhenrong, FU Yuan, CHEN Min, SHI Ruizan, ZHANG Xuanping.
Ursolic acid alleviates the injury of human aortic endothelial cells induced by high glucose and high fat#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 522-531.
|
| [14] |
XU Yongxia, XIE Mingzhu, GONG Muxue, HUANG Jiaying, ZHAO Li, ZHU Defa.
Effects of 25(OH)D on islet β-cells function in the elderly with type 2 diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1021-1026.
|
| [15] |
ZHAO Hailing, ZHANG Haojun, ZHAO Tingting, YAN Meihua, DONG Xi, MA Liang, LI Ping.
Association between the polymorphism of PNPLA2 gene and the risk of ischemic stroke in type 2 diabetic patients in Chinese Han Population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 664-669.
|
